ArticleISRN pediatrics2012

Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients.

Oliver Gross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.